1 line
19 KiB
Plaintext
1 line
19 KiB
Plaintext
{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T13:27:37Z","timestamp":1704720457367},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T00:00:00Z","timestamp":1674000000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T00:00:00Z","timestamp":1674000000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB 1382 (ID 403224013)","SFB 1382 (ID 403224013)","SFB 1382 (ID 403224013)","SFB 1382 (ID 403224013)"]},{"name":"Heisenberg professorship","award":["STR 1095\/6-1"]},{"name":"UFZ for the ProMetheus platform for proteomics and metabolomics"},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81804019"]},{"DOI":"10.13039\/501100004607","name":"Natural Science Foundation of Guangxi Province","doi-asserted-by":"publisher","award":["2018GXNSFBA050041"]},{"DOI":"10.13039\/501100007210","name":"RWTH Aachen University","doi-asserted-by":"crossref"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n <jats:title>Background and aim<\/jats:title>\n <jats:p>Since hepatocytes produce majority of serum proteins, patients with cirrhosis display substantial alterations in the serum proteome. The aim of the current study was to characterize these changes and to study the prognostic utility of hepatocellular proteins available in routine clinical testing.<\/jats:p>\n <\/jats:sec><jats:sec>\n <jats:title>Methods<\/jats:title>\n <jats:p>Sera from 29 healthy controls and 43 patients with cirrhosis were subjected to untargeted proteomic analysis. Unsupervised hierarchical clustering was performed with Perseus software and <jats:italic>R<\/jats:italic>. Ingenuity pathway analysis (IPA) suggested upstream regulators that were validated in liver tissues. The behavior and prognostic usefulness of selected biomarkers was investigated in 61 controls and 285 subjects with decompensated cirrhosis.<\/jats:p>\n <\/jats:sec><jats:sec>\n <jats:title>Results<\/jats:title>\n <jats:p>Proteomics uncovered 65 and 16 hepatocellular serum proteins that are significantly downregulated or upregulated in patients with cirrhosis vs. controls. Hierarchical clustering revealed two main clusters and six sub-clusters. IPA identified HNF4\u03b1 and IL-6 as the two major upstream regulators that were confirmed by hepatic gene expression analyses. Among pseudocholinesterase, transferrin, transthyretin, albumin, and apolipoprotein AI (Apo-AI), Apo-AI was the best predictor of 90-days transplant-free survival (AUROC 0.678; <jats:italic>p<\/jats:italic>\u2009=\u20090.0001) and remained an independent predictor in multivariable Cox independently of the presence of acute-on-chronic liver failure.<\/jats:p>\n <\/jats:sec><jats:sec>\n <jats:title>Conclusion<\/jats:title>\n <jats:p>Our study reveals cirrhosis-associated changes in hepatocellular serum proteins and underlying transcription factors. Serum apolipoprotein AI may constitute a useful prognostic adjunct in patients with decompensated cirrhosis.<\/jats:p>\n <\/jats:sec><jats:sec>\n <jats:title>Graphical abstract<\/jats:title>\n \n <\/jats:sec>","DOI":"10.1007\/s12072-022-10473-x","type":"journal-article","created":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T13:03:10Z","timestamp":1674046990000},"page":"698-708","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Biomarkers of hepatocellular synthesis in patients with decompensated cirrhosis"],"prefix":"10.1007","volume":"17","author":[{"given":"Berivan","family":"Gurbuz","sequence":"first","affiliation":[]},{"given":"Nurdan","family":"Guldiken","sequence":"additional","affiliation":[]},{"given":"Philipp","family":"Reuken","sequence":"additional","affiliation":[]},{"given":"Lei","family":"Fu","sequence":"additional","affiliation":[]},{"given":"Katharina","family":"Remih","sequence":"additional","affiliation":[]},{"given":"Christian","family":"Preisinger","sequence":"additional","affiliation":[]},{"given":"Radan","family":"Br\u016fha","sequence":"additional","affiliation":[]},{"given":"Martin","family":"Len\u00ed\u010dek","sequence":"additional","affiliation":[]},{"given":"Jarom\u00edr","family":"Petrt\u00fdl","sequence":"additional","affiliation":[]},{"given":"Johanna","family":"Reissing","sequence":"additional","affiliation":[]},{"given":"Mahmoud","family":"Aly","sequence":"additional","affiliation":[]},{"given":"Malin","family":"Fromme","sequence":"additional","affiliation":[]},{"given":"Biaohuan","family":"Zhou","sequence":"additional","affiliation":[]},{"given":"Isabel","family":"Karkossa","sequence":"additional","affiliation":[]},{"given":"Kristin","family":"Schubert","sequence":"additional","affiliation":[]},{"given":"Martin","family":"von Bergen","sequence":"additional","affiliation":[]},{"given":"Andreas","family":"Stallmach","sequence":"additional","affiliation":[]},{"given":"Tony","family":"Bruns","sequence":"additional","affiliation":[]},{"given":"Pavel","family":"Strnad","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2023,1,18]]},"reference":[{"key":"10473_CR1","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/cphy.c130024","volume":"4","author":"L Rui","year":"2014","unstructured":"Rui L. Energy metabolism in the liver. Compr Physiol. 2014;4:177\u2013197","journal-title":"Compr Physiol"},{"key":"10473_CR2","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.jhep.2018.04.018","volume":"69","author":"D Kuscuoglu","year":"2018","unstructured":"Kuscuoglu D, Janciauskiene S, Hamesch K, Haybaeck J, Trautwein C, Strnad P. Liver\u2014master and servant of serum proteome. J Hepatol. 2018;69:512\u2013524","journal-title":"J Hepatol"},{"key":"10473_CR3","doi-asserted-by":"crossref","unstructured":"Schrem H, Klempnauer J, Borlak J. Liver-enriched transcription factors in liver function and development. Part I: The hepatocyte nuclear factor network and liver-specific gene expression. Pharmacol Rev. 2002;54:129\u2013158.","DOI":"10.1124\/pr.54.1.129"},{"key":"10473_CR4","doi-asserted-by":"crossref","unstructured":"Schrem H, Klempnauer J, Borlak J. Liver-enriched transcription factors in liver function and development. Part II: The C\/EBPs and D site-binding protein in cell cycle control, carcinogenesis, circadian gene regulation, liver regeneration, apoptosis, and liver-specific gene regulation. Pharmacol Rev. 2004;56:291\u2013330.","DOI":"10.1124\/pr.56.2.5"},{"key":"10473_CR5","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nrgastro.2016.168","volume":"14","author":"P Strnad","year":"2017","unstructured":"Strnad P, Tacke F, Koch A, Trautwein C. Liver-guardian, modifier and target of sepsis. Nat Rev Gastroenterol Hepatol. 2017;14:55\u201366","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10473_CR6","doi-asserted-by":"publisher","first-page":"187","DOI":"10.2165\/00003088-200544020-00004","volume":"44","author":"DG Le Couteur","year":"2005","unstructured":"Le Couteur DG, Fraser R, Hilmer S, Rivory LP, McLean AJ. The hepatic sinusoid in aging and cirrhosis: Effects on hepatic substrate disposition and drug clearance. Clin Pharmacokinet. 2005;44:187\u2013200","journal-title":"Clin Pharmacokinet"},{"key":"10473_CR7","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1053\/j.gastro.2014.07.018","volume":"147","author":"T Luedde","year":"2014","unstructured":"Luedde T, Kaplowitz N, Schwabe RF. Cell Death and Cell Death Response in Liver Disease: Mechanisms and Clinical Relevance. Gastroenterology. 2014;147:765\u2013783","journal-title":"Gastroenterology"},{"key":"10473_CR8","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/nrgastro.2015.94","volume":"12","author":"G Szabo","year":"2015","unstructured":"Szabo G, Petrasek J. Inflammasome activation and function in liver disease. Nat Rev Gastroenterol Hepatol. 2015;12:387\u2013400","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10473_CR9","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jhep.2004.11.015","volume":"42","author":"F Durand","year":"2005","unstructured":"Durand F, Valla D. Assessment of the prognosis of cirrhosis: child-pugh versus MELD. J Hepatol. 2005;42:100\u2013107","journal-title":"J Hepatol"},{"key":"10473_CR10","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.jhep.2020.06.013","volume":"73","author":"J Trebicka","year":"2020","unstructured":"Trebicka J, Fernandez J, Papp M, et al. The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology. J Hepatol. 2020;73:842\u2013854","journal-title":"J Hepatol"},{"key":"10473_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2020.100221","volume":"3","author":"TH Wirtz","year":"2021","unstructured":"Wirtz TH, Reuken PA, Jansen C, et al. Balance between macrophage migration inhibitory factor and sCD74 predicts outcome in patients with acute decompensation of cirrhosis. JHEP Reports. 2021;3: 100221","journal-title":"JHEP Reports."},{"key":"10473_CR12","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1053\/j.gastro.2019.05.013","volume":"157","author":"K Hamesch","year":"2019","unstructured":"Hamesch K, Mandorfer M, Pereira VM, et al. Liver Fibrosis and Metabolic Alterations in Adults With alpha-1-antitrypsin Deficiency Caused by the Pi*ZZ Mutation. Gastroenterology. 2019;157:705-719.e18","journal-title":"Gastroenterology"},{"key":"10473_CR13","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.jhep.2008.12.024","volume":"50","author":"MH Tsai","year":"2009","unstructured":"Tsai MH, Peng YS, Chen YC, et al. Low serum concentration of apolipoprotein A-I is an indicator of poor prognosis in cirrhotic patients with severe sepsis. J Hepatol. 2009;50:906\u2013915","journal-title":"J Hepatol"},{"key":"10473_CR14","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jhep.2020.01.026","volume":"73","author":"M Trieb","year":"2020","unstructured":"Trieb M, Rainer F, Stadlbauer V, et al. HDL-related biomarkers are robust predictors of survival in patients with chronic liver failure. J Hepatol. 2020;73:113\u2013120","journal-title":"J Hepatol"},{"key":"10473_CR15","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","volume":"144","author":"R Moreau","year":"2013","unstructured":"Moreau R, Jalan R, Gines P, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology. 2013;144:1426-1437.e9","journal-title":"Gastroenterology"},{"key":"10473_CR16","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1016\/j.jhep.2021.01.018","volume":"75","author":"R Jalan","year":"2021","unstructured":"Jalan R, D\u2019Amico G, Trebicka J, Moreau R, Angeli P, Arroyo V. New clinical and pathophysiological perspectives defining the trajectory of cirrhosis. J Hepatol. 2021;75:S14\u2013S26","journal-title":"J Hepatol"},{"key":"10473_CR17","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.jhep.2017.10.020","volume":"68","author":"G D\u2019Amico","year":"2018","unstructured":"D\u2019Amico G, Morabito A, D\u2019Amico M, et al. Clinical states of cirrhosis and competing risks. J Hepatol. 2018;68:563\u2013576","journal-title":"J Hepatol"},{"key":"10473_CR18","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.jhep.2020.10.004","volume":"74","author":"D Costa","year":"2021","unstructured":"Costa D, Simbrunner B, Jachs M, et al. Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality. J Hepatol. 2021;74:819\u2013828","journal-title":"J Hepatol"},{"key":"10473_CR19","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.jhep.2014.06.012","volume":"61","author":"R Jalan","year":"2014","unstructured":"Jalan R, Saliba F, Pavesi M, et al. Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure. J Hepatol. 2014;61:1038\u20131047","journal-title":"J Hepatol"},{"key":"10473_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep32341","volume":"6","author":"C Sol\u00e9","year":"2016","unstructured":"Sol\u00e9 C, Sol\u00e0 E, Morales-Ruiz M, et al. Characterization of inflammatory response in acute-on-chronic liver failure and relationship with prognosis. Sci Rep. 2016;6:1\u201310","journal-title":"Sci Rep"},{"key":"10473_CR21","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.jhep.2015.11.021","volume":"64","author":"H Gr\u00f8nb\u00e6k","year":"2016","unstructured":"Gr\u00f8nb\u00e6k H, R\u00f8dgaard-Hansen S, Aagaard NK, et al. Macrophage activation markers predict mortality in patients with liver cirrhosis without or with acute-on-chronic liver failure (ACLF). J Hepatol. 2016;64:813\u2013822","journal-title":"J Hepatol"},{"key":"10473_CR22","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.jmb.2007.05.049","volume":"371","author":"Z Wang","year":"2007","unstructured":"Wang Z, Burke PA. Effects of hepatocyte nuclear factor-4\u03b1 on the regulation of the hepatic acute phase response. J Mole. 2007;371:323\u2013335","journal-title":"J Mole."},{"key":"10473_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-021-01917-6","volume":"19","author":"N Guldiken","year":"2021","unstructured":"Guldiken N, Argemi J, Gurbuz B, et al. Serum transferrin as a biomarker of hepatocyte nuclear factor 4 alpha activity and hepatocyte function in liver diseases. BMC Med. 2021;19:1\u201312","journal-title":"BMC Med"},{"key":"10473_CR24","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1101\/gad.4.12b.2353","volume":"4","author":"FM Sladek","year":"1990","unstructured":"Sladek FM, Zhong W, Lai E, Darnell JE. Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily. Genes Dev. 1990;4:2353\u20132365","journal-title":"Genes Dev"},{"key":"10473_CR25","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/hep.28450","volume":"64","author":"SS Desai","year":"2016","unstructured":"Desai SS, Tung JC, Zhou VX, et al. Physiological ranges of matrix rigidity modulate primary mouse hepatocyte function in part through hepatocyte nuclear factor 4 alpha. Hepatology. 2016;64:261\u2013275","journal-title":"Hepatology"},{"key":"10473_CR26","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.1038\/s41467-019-11004-3","volume":"10","author":"J Argemi","year":"2019","unstructured":"Argemi J, Latasa MU, Atkinson SR, et al. Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitis. Nat Commun. 2019;10:3126","journal-title":"Nat Commun"},{"key":"10473_CR27","doi-asserted-by":"crossref","unstructured":"Guzman-Lepe J, Cervantes-Alvarez E, Collin de l\u2019Hortet A, et al. Liver-enriched transcription factor expression relates to chronic hepatic failure in humans. Hepatol Commun. 2018;2:582\u2013594.","DOI":"10.1002\/hep4.1172"},{"key":"10473_CR28","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1080\/09674845.2018.1523673","volume":"76","author":"L Tan","year":"2019","unstructured":"Tan L, Meng Y, Zeng T, et al. Clinical diagnostic significance of prealbumin, cholinesterase and retinol binding protein in liver cirrhosis combined with encephalopathy. Br J Biomed Sci. 2019;76:24\u201328","journal-title":"Br J Biomed Sci"},{"key":"10473_CR29","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1038\/s41591-022-01850-y","volume":"28","author":"L Niu","year":"2022","unstructured":"Niu L, Thiele M, Geyer PE, et al. Noninvasive proteomic biomarkers for alcohol-related liver disease. Nat Med. 2022;28:1277\u20131287","journal-title":"Nat Med"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-022-10473-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-022-10473-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-022-10473-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T07:17:09Z","timestamp":1685171829000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-022-10473-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,18]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["10473"],"URL":"http:\/\/dx.doi.org\/10.1007\/s12072-022-10473-x","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":["Hepatology"],"published":{"date-parts":[[2023,1,18]]},"assertion":[{"value":"22 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare: no support from any organization other than the below mentioned ones for the submitted work; no financial relationships with any organizations that might have an interest in the submitted work in the previous 3\u00a0years; no other relationships or activities that could appear to have influenced the submitted work. Hence, all authors declare themselves to be independent from funders with respect to this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol conformed to the ethical guidelines of the 1975 Declaration of Helsinki and was approved by the Ethics committees of Jena University Hospital (2880\u201308\/10, 3683\u201302\/3, 3150\u201306\/11), Aachen University Hospital (EK 173\/15), by the Ethics committees of First Faculty of Medicine and Prague General University Hospital (MZ10-UK1LF-BruhaRadan-B).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"We attest that we did not use any copyright protected material in our manuscript. No writing assistance was provided.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Further remarks"}}]}} |